1 asset in CDH1-Related Diffuse Gastric And Lobular Breast Cancer Syndrome

Therapeutic assets addressing CDH1-Related Diffuse Gastric And Lobular Breast Cancer Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tamoxifen CDH1-Related Diffuse Gastric And Lobular Breast Cancer Syndrome	European Institute of Oncology	P2	CCC (53)